Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · INDRAMEDCO

INDRAPRAST

HealthcareHealthcare Services₹3295 cr market cap
₹360.35 ▲ +0.66% today As of 19 Nov 2026
52-week low ₹299.8052-week high ₹548.15

-34.7% from the 52-week high · +19.4% above the low

Indraprastha Medical Corp. Ltd. engages in the healthcare business. The company is headquartered in New Delhi, Delhi and currently employs 2,947 full-time employees. The business activities of the Company are running and operating hospitals, which include Indraprastha Apollo Hospitals and Apollo Hospitals. The firm provides various services, such as in-patients, out-patients and clinical services. Indraprastha Apollo Hospitals is a multi-specialty tertiary acute care hospital with approximately 710 beds and is spread over 15 acres and has a built-up area of over 600,000 square feet. Indraprastha Apollo Hospitals has various specialties, such as anesthesia, cardiology, cardiac surgery, cancer, pediatrics, critical care, emergency care, fetal medicine, gastroenterology and hepatology, obstetrics and gynecology, interventional radiology, IVF, liver and kidney transplant, nuclear medicine, nephrology, ophthalmology, plastic and reconstructive surgery, respiratory and sleep medicine, rheumatology, spine surgery, urology and andrology.

The short version. Promoter holding was 51.0% in Sep 2026, up 0.00 points over 8 quarters.

1 · The price

How has the stock traded?

INDRAPRAST trades 34.7% below its 52-week high and 19.4% above its 52-week low.

Change over period: —

1M+13.5%
3M-4.4%
6M-0.5%
1Y-31.2%

4 · The owners

Who holds it, and are they adding?

Promoter holding51.0%

Unchanged over 8 quarters.

Foreign institutions2.39%

Down 0.49 pts over 8 quarters.

Domestic institutions1.77%

Down 1.42 pts over 8 quarters.

Mutual fund schemes7

+2 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Change
Promoter51.051.051.051.051.051.051.051.00.0
FII2.882.942.722.412.732.442.772.39-0.49
DII3.193.563.563.510.830.880.591.77-1.42
Public42.9342.5142.7243.0845.4445.6945.6444.84+1.91

Mutual fund holdings · Oct 2026

7 schemes hold this stock

5 the month before.

  • ICICI Prudential Healthcare Fund0.83% of NAV
  • Groww BSE Hospitals ETF0.62% of NAV
  • Motilal Oswal BSE Healthcare ETF0.08% of NAV
  • Bandhan BSE Healthcare Index Fund0.08% of NAV
  • Motilal Oswal BSE 1000 Index Fund0.01% of NAV
  • ADITYA BIRLA SUN LIFE BSE TOTAL MARKET ETF0.01% of NAV
  • ADITYA BIRLA SUN LIFE BSE TOTAL MARKET INDEX FUND0.01% of NAV

See what mutual funds are buying

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for INDRAPRAST are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about INDRAPRAST

What is the INDRAPRAST share price?

INDRAPRAST (INDRAMEDCO) last closed at ₹360.35, up 0.66% on the day. Its 52-week range is ₹299.80 to ₹548.15.

What is the market cap of INDRAPRAST?

INDRAPRAST has a market capitalisation of about ₹3,295 crore. Its price-to-earnings ratio is 17.2.

How are INDRAPRAST's latest results?

Promoter holding was 51.0% in Sep 2026, up 0.00 points over 8 quarters.

Who owns INDRAPRAST?

As of Sep 2026, shareholding was: Promoter 51.0%, FII 2.39%, DII 1.77%, Public 44.84%.

How many mutual funds hold INDRAPRAST?

7 mutual fund schemes held INDRAPRAST in October 2026. That compares with 5 the month before.

Corporate actions

Recent dividends, bonuses and splits

  • 18 Sep 2025 · Final Dividend - Rs. 4.5
  • 13 Sep 2024 · Final Dividend - Rs. 4.5
  • 15 Sep 2023 · Dividend - Rs. 3
  • 15 Sep 2022 · Dividend - Rs. 2.5
  • 12 Sep 2019 · Dividend - Rs. 1.6
  • 12 Sep 2018 · Dividend - Rs. 1.5

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.